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Abstract Heligmosomoides polygyrus is a natural intesti-
nal parasite of mice, which offers an excellent model of
the immunology of gastrointestinal helminth infections
of humans and livestock. It is able to establish long-
term chronic infections in many strains of mice, exert-
ing potent immunomodulatory effects that dampen both
protective immunity and bystander reactions to allergens
and autoantigens. Immunity to the parasite develops
naturally in some mouse strains and can be induced in
others through immunization; while the mechanisms of
protective immunity are not yet fully defined, both anti-
bodies and a host cellular component are required, with
strongest evidence for a role of alternatively activated
macrophages. We discuss the balance between resistance
and susceptibility in this model system and highlight
new themes in innate and adaptive immunity, immuno-
modulation, and regulation of responsiveness in helminth
infection.
Introduction
Heligmosomoides polygyrus: a model organism
Chronic helminth infections remain a huge global health
problem, causing extensive morbidity in both humans and
livestock. Many of the most prevalent helminth parasites
are difficult to study in the laboratory, as they have co-
evolved with, and are closely adapted to, their definitive
host species. However, model organisms such as Heligmo-
somoides polygyrus, a natural mouse parasite, offer trac-
table and informative systems to explore the mechanisms
of immunity and immune evasion in helminth infections
[1, 2].
H. polygyrus (previously named Nematospiroides dubius)
is an intestinal nematode parasite in wild mouse populations
that has successfully been transferred to the laboratory. It is
phylogenetically placed in the same Suborder, Trichostrongy-
lina, as the ruminant parasites Haemonchus contortus and
Teladorsagia circumcincta andwithin the sameOrder, Strong-
ylida, as the human hookworm parasites Ancylostoma duode-
nale and Necator americanus [3]. H. polygyrus is an
appropriate model of these chronic helminthiases, as primary
infections can persist for many months in susceptible strains
of mice.
In an experimental setting, H. polygyrus is introduced by
orally gavaging mice with infective L3 larvae. Following
ingestion, within 24 h, larvae have penetrated through into
the submucosa of the small intestine. Here they undergo two
developmental molts, before emerging back into the lumen
as adult worms, which feed on host intestinal tissue [4]. The
adult worms coil around the small intestine villi to secure
themselves, mate, and produce eggs, which are excreted in
the feces. In the external environment, the eggs hatch and
undergo two molts to become infective L3s, and so the
lifecycle continues (Fig. 1).
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The persistence ofH. polygyruswithin the murine host can
be measured by determining the number of eggs that are
released in the feces, or by enumerating adult worms remain-
ing in the small intestine. As described below, the wide range
of reagents available for assaying and manipulating the mu-
rine immune system cells in mice are being effectively applied
to investigate responsiveness and immunity. The mechanisms
behind helminth expulsion in mice can therefore be studied in
order to make predictions about similar interactions between
helminths and the immune system in livestock and humans,
with a view to developing much-needed vaccines for control
of these infections.
A further advantage ofH. polygyrus is that the mammalian
stages can be cultivated in vitro, where its secretory products,
H. polygyrus excretory–secretory antigens (HES), can be
collected, and individual components can be purified and
identified [5]. This provides a fruitful strategy to test defined
parasite molecules in vitro and in vivo for immunomodulatory
functions and as candidate vaccine antigens.
Genetics of susceptibility to H. polygyrus
In primary infections of different mouse strains, the length
of time H. polygyrus can persist and the degree of response
it provokes shows considerable variation, and some genotypes
are also poor at rejecting challenge infections following
immunisation.
Table 1 shows a summary of “responsiveness” to H.
polygyrus in different mouse strains, based on adult worm
survival and fecundity after primary and secondary infec-
tion. The genetic factors controlling strain differences in
resistance to infection include the major histocompatibility
complex (MHC) H-2 loci, with weak responders among the
H-2k and H-2b genotypes and the H-2q or H-2s genotypes
associated with a rapid response [6, 7].
Experiments in H-2 congenic C57BL/10 mouse strains
show that although establishment of H. polygyrus larvae is
equal between all strains (shown by worm counts 2 weeks
postinfection), by week 9, egg and adult worm numbers differ
strikingly. Those with H-2s and H-2q haplotypes expelled the
parasites more rapidly [7, 8], while mice carrying H-2b
or H-2k haplotypes backcrossed into the fast-responding
BALB/c background were unable to expel worms quickly
[7]. Resistance was shown to be conferred by more than one
gene, as F1 hybrids of fast responders, SJL and SWR, display
heightened abilities to expel worms, and is inherited in a
dominant fashion as C57BL/10xSJL hybrids are as rapid in
expulsion as the SJL parental strain [7, 9].
More recently, a study mapping quantitative trait loci in
fast responding (SWR, H-2q) versus slow responding (CBA,
H-2k) strains found significant effects on resistance to H.
polygyrus trickle infection from positions on chromosomes
1, 2, 13, and 17 [10]. Several candidate resistance genes
were identified, including as expected MHC (on chromo-
some 17), and also interleukin-9 (IL-9; on chromosome 13),
both of which correlate with worm expulsion [10].
A notable gender bias in susceptibility is also observed,
with female mice of all strains clearing primary infections
faster than their male counterparts as also apparent to a
lesser degree following secondary exposure [11–13]. The
greater susceptibility of male mice correlates with higher
fecundity of worms recovered from male hosts and a larger
adult worm body size [14], indicating that the parasites are
fitter than those from a female host.
Concurrent pregnancy and worm infection imposes in-
creased physiological demands on the mother in terms of the
energy required to fight infection and to nourish the fetus.
This can lead to immunosuppression (diminished Th2
responses) [15] and adverse reproductive outcomes (small
pup size) [15, 16]. The effects of pregnancy on maternal
serum cytokines during H. polygyrus infection include
Fig. 1 Lifecycle of
Heligmosomoides polygyrus in
mice
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increased levels of IL-1β and IL-6 at day 20 postinfection
[15] and lower concentrations of IL-4, IL-5, IL-13, and
mucosal mast cell protease (mMCP-1) [15]. Pregnant mice
also show a small but significant increase in adult worm
burdens [15].
Models of resistance
Immunity to H. polygyrus can be studied in three separate
settings each with distinct implications for human infection,
namely, genetically determined, drug-induced, and vaccine-
elicited immunity. In each of these contexts, the availability of
numerous gene-targeted mouse strains and immunological
reagents are being used to define immune system components
and parameters required for immunity to infection.
As stated above, the outcome of primary H. polygyrus
infection is strongly influenced by the genetic background of
mice, with strains differing in their susceptibility to chronic
infection. Studying how the immune response differs between
those strains that endure chronic infections and those that are
able to clear a primary infection has been highly instructive in
defining the immune mechanisms the host must promote in
order to clear the parasite.
If primary infection with H. polygyrus is cleared using
antihelmintic drugs such as pyrantel pamoate or ivermectin
[17], most mouse strains display a highly effective memory
response, which provides immunity to reinfection [18]. Ge-
netic background also impacts on resistance to reinfection, as
BALB/c mice display significantly lower worm numbers
postchallenge compared to C57BL/6 [19, 20].
Finally, HES administered in alum adjuvant has been
shown to induce sterilizing immunity to H. polygyrus infec-
tion [21], and studies are ongoing to identify the specific
components of HES and the immune mechanisms critical
for this immunity.
Challenge infection/Trickle infection
Although most laboratory studies employ a single bolus in-
fection, doses used are far from physiological or representa-
tive of field conditions. Hence, some investigators have
developed trickle infection regimes, for example, administer-
ing twice weekly low doses of infective larvae. Under these
conditions, different mouse strains show a gradation of resis-
tance patterns similar to those seen with single-bolus primary
infection, in that NIH and SWR strains resolve infection
(showing an initial increase in adult worm burden, a period
of stability, and then finally expulsion) while CBA and
C57BL/10 mice continue to accumulate increasing adult
worm burdens over the course of repeated infections [22].
Variation and adaptation by H. polygyrus
The strain of H. polygyrus used in laboratories worldwide is
thought to have been isolated from wild Californian mice in
the 1940s [23] and was known for some years as Nematospir-
oides dubius. The vast majority of the literature describing
Table 1 Strain-specific immu-
nity to H. polygyrus Responsiveness Strain Immune mechanisms investigated
Slow (>20 weeks to
expel worms)
CBA Primary response involves significantly lower cell numbers in the
MLN than other strains [193, 194], very few mast cells in the
gut [193], low levels of mMCP in serum and intestinal lavage








C57BL/6 C57BL/10 mice show less rapid and lower eosinophilia levels in
circulation, after both primary H. polygyrus infection or injection
of parasite antigens, than NIH mice [196]
C57BL/10
129/J
Fast (6–8 weeks) DBA/2 NIH mice produced a higher peak of lymphocytosis, neutrophilia




Rapid (4–6 weeks) SJL SJL and SWR have quicker and stronger antibody responses than
other strains, involving stronger recognition of a larger number of
antigens on a Western blot of HES [198] and adult homogenate
[193], and higher titers of parasite-specific antibody of different
isotypes in serum [51, 193, 198]
SWR Infected SWR MLN cells produced higher levels of IL-3, IL-4 and
IL-9 after ConA stimulation than NIH and CBA [52]
Both strains show early peaks of serum tumor necrosis factor alpha,
mMCP-1, intestinal mast cells and goblet cells, which precede the
expulsion of the worms [51, 53]
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experiments with this isolate refers to the parasite as H. poly-
gyrus. It was, however, suggested that this laboratory strain
should be referred to asH. polygyrus bakeri, to differentiate it
fromwild strains of the parasite, considered to beH. polygyrus
polygyrus (found in the wood mouse Apodemus sylvaticus in
Europe), H. polygyrus corsicus (from the house mouse Mus
musculus in Corsica) and H. polygyrus americanus (from the
vole Phenacomys intermedius in North America) [24]. More
recently, there has been an additional proposal of a name
change for the laboratory isolate to H. bakeri [23], based on
sequence divergence between laboratory and European wood
mouse isolates [25]. This proposal has not received wide-
spread support due to the preliminary nature of the data, the
sequence variation even within the laboratory strain, and the
need to remain consistent with previous literature [26]. Here,
we refer to the laboratory strain of the parasite asH. polygyrus.
In proteomic studies on H. polygyrus secreted antigens
(see below), extensive sequence variation was observed in
some gene families [5], indicating that despite many years
of laboratory propagation, the parasite strain remains highly
polymorphic. Moreover, there are indications that antigen
expression by H. polygyrus may vary or adapt according to
the host strain of mouse [27, 28], with proteomic differences
in adult worms recovered 4 weeks postinfection in either
C57BL/10 (slow responder) or SWR (fast responder) hosts
[28]. Phosphatidylethanolamine-binding protein and several
nematode globins are overexpressed in worms fromC57BL/10
compared to worms from SWR mice, and myosin, troponin,
actin, and several unidentified proteins are overexpressed in
the worms from fast responder mice compared to slow [28].
Differential expression of worm products in different host
strains may shed light on pathways targeted by the immune
system that impact on worm survival or death.
Host immune responses
The critical requirement for the adaptive immune response
in control of the parasite is illustrated when B- and T-cell
responses are lacking. Severe combined immunodeficient
(SCID; B- and T-cell deficient) and athymic mice show
impaired expulsion of adult worms, maintaining high
worm burdens several weeks post infection by which
stage wild-type counterparts had expelled the majority of
their worms [29, 30]. Treatment with anti-CD4 results in
higher fecundity of female worms in a primary infection
[31] and transfer of the effector T-cell subset from chronically
infected animals significantly reduced worm burdens when
transferred to naive mice before infection [32]. Although B-
cell deficiency does not affect the outcome of primary H.
polygyrus infection, B-cell or antibody deficiency significant-
ly compromises the ability to expel a secondary challenge
infection [33].
T-cell responses
H. polygyrus infection induces a strongly polarized Th2
response, which has been shown to be critical in control
and expulsion of the worm [31]. A primary H. polygyrus
infection induces IL-3, IL-4, IL-5, and IL-9 gene expression
in the mesenteric lymph nodes (MLN) and Peyer’s patches
[34] and elicits the release of high concentrations of IL-4,
IL-5, IL-9, IL-10, and IL-13 protein from MLN, spleen, and
lamina propria mononuclear cells (LPMC) cultured with
parasite antigens [32, 35, 36]. IL-4 is the most critical single
cytokine for protection against primary and secondary H.
polygyrus infection (both in expulsion of adult worms and
inhibiting their egg production) [31]. Immunity to secondary
infection is diminished by blocking antibody to IL-4 but
completely abolished when the IL-4R is also blocked [31].
This suggests that IL-13, which also signals through IL-
4Rα, can partially compensate for the loss of IL-4, but in
the absence of signaling from both cytokines, protection
against reinfection with H. polygyrus is lost. Blocking of
IL-5 by antibody treatment had no effect on worm expulsion
[31]. When IL-4 is administered as a complex with anti-IL-4
(IL-4C) to extend the activity time of this cytokine, wild-
type BALB/c mice expelled H. polygyrus more rapidly [29].
This effect did not depend on the adaptive immune system,
as H. polygyrus expulsion was also seen in SCID mice and
anti-CD4-treated BALB/c mice, which were given the IL-4
complex [29]. After primary infection, CD4+IL-4+ T cells
disseminate around the body to lymphoid and nonlymphoid
organs, such as airways, peritoneal cavity, and liver, and
have a lower apoptotic potential [37, 38]. These findings
may be illustrative of peripheral reservoirs of long-lived
memory Th2 cells primed to respond to subsequent infec-
tion challenges by the worm.
Further studies have delineated the costimulatory signals
required tomount Th2 responses toH. polygyrus infection. By
blocking signaling through both CD80 (B7-1) and CD86 (B7-
2) with specific antibodies or a CTLA4-Ig construct, IL-4
expression, Th2 expansion, and IgE production in response
to H. polygyrus were ablated [39, 40]; interestingly, an innate
IL-5 response remained intact when T-cell costimulation was
inhibited. Blocking antibodies against CD80 or CD86 alone
had little effect [40], and while early (day 6 postinfection)
responses to H. polygyrus were unaltered in CD86-deficient
mice [41], by day 14 postinfection, CD86-deficient mice had
higher parasite egg burdens and decreased Th2 responses
[41]. This showed that, while CD86 was not required for the
initiation of the antiworm response, it was necessary for its
progression and persistence.
Although both CD80 and CD86 normally ligate to T-cell
CD28, CD28-deficient mice were found to have no impair-
ment in the early CD4+IL-4+ response, indicating an alter-
native mechanism for Th2 costimulation in H. polygyrus
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infection [42]. Moreover, while the primary T-cell response
to infection is CD80/CD86-dependent as outlined above, on
secondary infection, memory helper T cells do not require
CD80 or CD86 costimulation for their activation to protect
against challenge [43, 44]. Studies into an additional costi-
mulatory molecule, OX40L (CD143), showed that it is
specifically required to promote IL-4 production from T
cells (and the associated rise in IgE), without affecting
Th2-cell expansion, migration, germinal center formation,
or IgG1 levels [45].
T-follicular helper cells are now recognized as the instru-
mental subset, which induces germinal center formation and
isotype switching in B cells, by migrating to B-cell follicles
and releasing cytokines including IL-21 [46], while also
producing IL-4 in the MLN of H. polygyrus-infected mice
[47]. IL-21 plays key roles by stimulating multiple cell types
across a range of infections [48]. In H. polygyrus infection,
IL-21 deficiency results in reduced intestinal granuloma
formation, impaired T-cell expansion and survival, and low-
er numbers of circulating basophils and eosinophils [49]. IL-
21 also provides a critical signal for the differentiation of B
cells into plasma cells and for protection against secondary
challenge infection with H. polygyrus [50].
B-cell and humoral responses
In general, the intensity and speed of parasite-specific anti-
body responses are greater in more resistant mouse strains
such as SJL and SWR than in susceptible strains. Specifically,
the IgG1 and IgE responses (to adult worm homogenate and
HES) negatively correlate across strains with worm survival
after a primary infection [12, 51, 52]. However, after repeated
low-dose (“trickle”) infections, there was little difference be-
tween slow and fast responder strains in any antibody isotype
measured to larval and worm antigens [53].
B cells, as well as secreting antibodies, also produce
cytokines and costimulatory molecules that promote and
amplify the T-cell response in a selective manner [54, 55].
Interestingly, the greatest increase in cell number in MLN
after H. polygyrus infection is in the B-cell compartment
[32, 56].
The protective response to secondary challenge with H.
polygyrus is dependent on B cells, as μMT and JHD mice
(both of which lack B cells) cannot clear the parasites [57–59].
Defective immunity in B-cell-deficient mice is not due to an
impairment of Th2 responses, or to T regulatory cell (Treg)
activation, development, or differentiation, as a pronounced
local Th2 response in the intestinal tissues occurred with or
without B cells, in both primary and secondary infection [58,
59]. However, a separate study showed impairment of the Th2
response in B-cell deficient mice, with significantly lower T-
cell expansion and cytokine production [57]. These authors
showed that a sufficient T-cell memory response was B-cell
dependent and that immunity required B cells to produce the
cytokines IL-2 and tumor necrosis factor alpha [57]. This
discrepancy remains unclear, and B cells seem to have differ-
ing roles in other helminth infections. During a primary infec-
tion with the colon-residing murine nematode parasite
Trichuris muris, B cells are required for resistance and the
development of a Th2 response [60]; however, in primary and
secondary infection with another gastrointestinal nematode,
Nippostrongylus brasiliensis, Th2 responses and worm expul-
sion are B-cell independent [58].
The specific role of antibody in mediating protection
against H. polygyrus has also been investigated using mice
with targeted deficiencies within the B-cell compartment.
For example, μs mice have secretory IgM-deficient B cells,
but can produce parasite-specific class-switched IgG1 and
IgE, and are able to clear secondary infection [57]. Howev-
er, when crossed with a null activation-induced deaminase
transgene, the resultant mice are unable to undergo affinity
maturation or secrete antibody of any isotype and are not
protected from secondary challenge with the parasite [57].
Using selective isotype knockout mice given a secondary H.
polygyrus infection, it was found that IgE had no role in
protection, and IgA had a minor role, leaving IgG as the
major class-switched isotype leading to protection [59].
Indeed, it has been long known that the humoral response
is dominated by parasite-specific IgG1 and that serum frac-
tions with highest parasite-specific IgG1 activity afford
greater protection when transferred to an infected animal
[61]. Even transfer of whole serum from immune wild-type
donors to JHD-recipient mice can significantly reduce the
number of adult worms left in the intestine after a challenge
infection [58].
Primary H. polygyrus infection also elicits an extraor-
dinary increase in nonspecific serum IgG1 levels
(hypergammaglobulinemia) [59, 61, 62], and following re-
peated trickle infections over 4 weeks, serum IgG1 concen-
trations can reach 30 times the normal level seen in uninfected
mice [62, 63]. Despite these high concentrations, transfer of
serum from 28-day infected mice does not protect naive
animals from infection [59, 64]. In contrast, serum raised after
multiple H. polygyrus infections is protective against adult
worm survival when transferred into naive recipients [64, 65],
presumably reflecting the higher ratio of parasite-specific to
nonspecific IgG following repeated infection. The mecha-
nisms through which such high levels of polyclonal IgG1
are produced in response to H. polygyrus (and other parasitic
worms [63]) remain to be explored.
Innate immune responses
Innate immune cells are the initial responders to a H. poly-
gyrus infection and are also implicated in the end-stage
expulsion of parasites. Innate cells release type 2 cytokines
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that can act directly to alter gut physiology and polarize the
adaptive immune response, while themselves employing
helminth-damaging or killing mechanisms [66, 67].
Dendritic cells
Dendritic cells (DCs) are the predominant innate antigen-
presenting cell that are required to prime Th2 responses
against helminths [68]. DCs loaded with helminth products
in vitro can be transferred to naive animals to induce a Th2
response [69] and have been shown to inhibit allergic air-
way inflammation when transferred from a helminth-
infected animal, resulting in increased numbers of Tregs
and a downregulation of Th2-mediated inflammation [70].
When CD11c+ DCs are depleted using CD11c.DTR mice
[71] that coexpress CD11c with the human diphtheria toxin
receptor (DTR), a Th2 response against several helminths
(including H. polygyrus) is severely compromised [72, 73].
Macrophages
The alternative activation of macrophages is a hallmark of
helminth-elicited Th2 responses and is associated with high
expression of a characteristic set of gene products, including
Ym1, RELM-α (FIZZ-1), arginase-1, IL-4Rα, and the man-
nose receptor CD206 [66, 74]. Macrophages can differen-
tially express the enzymes nitric oxide synthase 2 (NOS-2)
and arginase-1, which compete for the common substrate L-
arginine, and are competitively induced by interferon gam-
ma (IFN-γ) and Th2 cytokines (IL-4, IL-10, IL-13, and IL-
21), respectively [75–78]. The activation state of macro-
phages in helminth infections is sufficiently plastic to re-
spond to changing stimuli, as helminth-induced alternatively
activated macrophages restimulated ex vivo with lipopoly-
saccharide and IFN-γ switch to a classically activated phe-
notype [79], suggesting that such plasticity may also occur
in vivo.
Alternatively activated macrophages are critical to the
protective immune response to secondary H. polygyrus in-
fection, as mice lost the ability to reject challenge infections
when depleted of macrophages via clodronate treatment, or
when treated with S-(2-boronoethyl)-l-cysteine (BEC), a
pharmaceutical inhibitor of arginase [80]. Arginase-1 may
directly harm parasites, as H. polygyrus exhibited higher
levels of cytochrome oxidase, a marker of a stress response,
in a secondary infection compared to a primary infection,
and this increase was lost following BEC administration
[80]. In contrast to arginase, no antiparasite function has
been found for Ym1, a member of the chitinase-like family
of proteins that lacks demonstrable chitinase activity [81].
Ym1 does bind heparin on cell surfaces and in the extracel-
lular matrix [81], which may indicate a role for Ym1 and
alternatively activated macrophages in mediating repair of
tissue damage caused by H. polygyrus when migrating
through the intestinal wall [82].
Alternatively activated macrophages may also be impor-
tant mediators of the smooth muscle hypercontractility re-
sponse to intestinal helminth infections, at least in the
context of a N. brasiliensis infection, as depleting macro-
phages via clodronate-treatment blocked smooth muscle
hyperactivity and impaired worm expulsion [83].
Neutrophils
Perhaps surprisingly, the role of the principal granulocyte cell
types (neutrophils, eosinophils, and basophils) has not been
directly evaluated in H. polygyrus infection. Neutrophils are
prominent in primary and, to a lesser extent, secondary gran-
ulomas during a H. polygyrus infection [80, 84, 85]. The
finding that neutrophils are less prevalent in a setting of
heightened resistance may indicate that they are not a key cell
type in immunity. To date, a protective function for neutro-
phils during helminth infections has only been reported for
infections of mice with tissue-migrating larvae of the human
nematode parasite Strongyloides stercoralis, although even in
this case killing was more effective when eosinophils were
present alongside neutrophils [86, 87].
Eosinophils
No role for eosinophils in H. polygyrus expulsion has yet
been described. In a genetic model of eosinophil deficiency,
in which an eosinophil-specific site in the GATA-1 promoter
is deleted [88], mice showed impaired resistance to chal-
lenge infections with N. brasiliensis [89]; significantly, in
the absence of eosinophils, greater numbers of tissue larvae
migrated to the lung, but expulsion of those parasites that
subsequently reached the gut was unimpaired in the
eosinophil-deficient mice. Eosinophilia in response to N.
brasiliensis infection was blocked when mice were admin-
istered anti-IL-5 antibody [90, 91], but this had no impact on
adult worm recovery [90], providing additional evidence
that eosinophils are not a critical mediator of expulsion in
this system. Anti-IL-5 treatment during H. polygyrus infec-
tion also had no impact on worm burden [92], and eosino-
phils within the gut wall have been reported to be inhibited
during H. polygyrus infection in a manner reversible with
anti-transforming growth factor beta (anti-TGF-β) antibody
treatment [93].
Basophils
As with the other granulocytes, few studies have investigat-
ed the role of basophils in H. polygyrus infections. In other
gastrointestinal nematode infections, basophilia is conspic-
uous, and their presence may be required for optimal N.
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brasiliensis expulsion [94]. Worm expulsion of T. muris was
impaired when basophil numbers were depleted using
MAR-1 antibody [95]; however, this antibody targets the
FcεRI, which is also expressed by mast cells, so this does
not conclusively prove a role for basophils alone.
Mast cells
Mast cells are major players in the intestinal immune re-
sponse to infection with H. polygyrus, as expulsion corre-
lates with epithelial mastocytosis [52, 96] and elevated
intestinal fluid levels of mMCP-1 in different murine strains
[51]. Mast cells may promote helminth damage by increas-
ing the permeability of the gut via mMCP-1-mediated
breakdown of epithelial tight junction proteins [97, 98],
thereby increasing luminal flow and disrupting the niche
of parasitic helminths. Increased permeability of the gut in
response to Trichinella spiralis is blocked in mMCP-1-
deficient mice, which were less effective at clearing the
worms than wild-type counterparts [98]. The mast cell re-
sponse to T. spiralis (and N. brasiliensis) infection, howev-
er, is ablated in mice carrying an H. polygyrus coinfection
[99] arguing that the latter parasite is able to suppress host
mastocytosis to a significant degree.
Most in vivo studies on mast cells in helminth infection
have involved the mast-cell-deficient mice KitW/KitW-v which
carry a mutated gene encoding the tyrosine kinase receptor c-
kit. DuringH. polygyrus infections, these mice produce higher
egg numbers than wild-type controls, indicative of impaired
immunity [100]. Consistent with this, reduced egg production
was seen in Tg2Rbetamice [101], which exhibit mastocytosis.
In terms of protective immunity to adult worms, howev-
er, KitW/KitW-v mice were found to be similar to wild type in
slowly expelling primary H. polygyrus infection between 4
and 9 weeks of infection [100]. However, a more recent
report has that shown KitW/KitW-v mice and another mast cell
deficient strain, KitW-sh mice, do have impairments in H.
polygyrus expulsion, as both strains had higher worm bur-
dens than wild-type mice after 3 weeks of a primary H.
polygyrus infection [102]. The same authors also showed
that KitW/KitW-v mice were not resistant to a secondary H.
polygyrus infection, yet control wild-type mice were able to
clear the infection [102]. The reason for the discrepancy
between the reports on the ability of KitW/KitW-v mice to
clear H. polygyrus is not clear, and more studies are required
to confirm the importance of mast cells during infections. If
mast cells do contribute to expulsion of H. polygyrus, it
could be via their contributions towards priming a Th2
response early in infection, as well as their potential role
as a later effector cell. KitW/KitW-v MLN cells did not show
the high levels of H. polygyrus-antigen-specific Th2 cyto-
kines produced by wild-type MLN cells in response to H.
polygyrus [102].
It should be noted that both KitW/KitW-v and KitW-sh mice
have defects that extend beyond a mast cell deficiency [103].
Many of the recently described subsets of lineage negative
innate type 2 cells, discussed below, express c-kit, and so it is
likely that some of the deficiencies of KitW/KitW-v and KitW-sh
mice can be explained by the additional disruption of these
cell types.
Innate lymphoid cells
Recently, a number of studies have identified a population
of lineage marker negative innate lymphoid cells (ILC),
which produce type 2 cytokines (particularly IL-5 and IL-
13) in response to epithelial cell-derived cytokines, includ-
ing IL-25, IL-33, and thymic stromal lymphopoietin
(reviewed in [104]). IL-25 may also be derived from other
cell types, such as mast cells [105], but the importance of
IL-25 from this source is as yet unknown. Epithelial cells
produce elevated levels of these cytokines in response to
damage, thereby raising the first alarm leading to Th2
responses (reviewed in [106]). Trefoil factor 2 (TFF2) is a
molecule involved in epithelial cell repair, which induces
IL-33 production by epithelial cells in response to damage
caused by N. brasiliensis [107]. TFF2−/− mice did not show
the elevated epithelial IL-33 levels in response to N. brasi-
liensis that wild-type mice did, instead having lower serum
IL-4 levels after 7 days of infection, and delayed worm
expulsion [107]. Similarly, Th2 cytokine production is
delayed, and N. brasiliensis expulsion is impaired in IL-
25−/− mice, which correlates with the absence of a non-B
non-T-cell c-kit+ IL-4, IL-5, and IL-13 producing population
induced in infected wild-type mice or mice administered
rIL-25 or rIL-33 [108–110]. A role for ILCs has not yet
been reported during a H. polygyrus infection though it
seems likely that these cell types are important inducers of
Th2 responses during all intestinal helminth infections.
Gut physiology and intestinal epithelial cell function
IL-4 and IL-13, derived from innate or adaptive sources,
are likely to have direct effects on the physiology of the
gut as well as on effector cells that promote helminth
expulsion. Although few changes in epithelial cell func-
tion are noted during primary H. polygyrus infection, in
secondary infections, increased mucosal permeability, de-
creased ion absorption, and increased prosecretory effects
in response to prostaglandin E2 and histamine were seen
[111, 112]. Moreover, these changes were dependent on
the IL-4R and STAT6 and were reproduced by IL-4C
administration [111, 112]. These alterations to the worm’s
environment may interfere with its abilities to feed on the
intestinal tissue [4] or remain wrapped around the villi in
the small intestine.
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Goblet cell function
Within the intestinal epithelial layer are specialized goblet
cells that secrete innate defence proteins as well as large
quantities of mucins, the key components of mucus. Goblet
cell hyperplasia develops in response to intestinal helminth
infections, including H. polygyrus, where hyperplasia is
dependent on a functional T-cell response [30].
Enhanced mucus production has been suggested to act
against helminth establishment, and it may be that specific
components within the mucus play a role in control of
helminth expulsion. RELM-β (FIZZ-2) is a cysteine-rich
mediator expressed by goblet cells in response to IL-13
and is important for the normal control of epithelial cell
barrier permeability [113, 114]. RELM-β−/− mice do not
expel a secondary H. polygyrus infection as rapidly as
wild-type mice and adult H. polygyrus worms treated in
vitro with recombinant RELM-β prior to transfer to a new
host survived less well than untreated adult worms [115].
This suggests that RELM-β is an important factor in inhib-
iting worm survival, perhaps by interfering with worm che-
motaxis and nutrition [113, 115]. Secretion of MUC2, a
major component of mucus in both the small and large
intestine, is also upregulated during a H. polygyrus infection
[30]. No evidence for a role for MUC2 in expulsion of H.
polygyrus has yet been reported; however, MUC2 produc-
tion correlates with the expulsion of T. muris [116, 117] and
N. brasiliensis [118].
Smooth muscle contraction
Both IL-4 and IL-13 enhance smooth muscle contractility in
the small intestine [119], a mechanism that has been shown
to be important for resistance to other helminth infections
including Schistosoma mansoni [120], T. spiralis [121,
122], and N. brasiliensis [123]. Increased intestinal smooth
muscle contractility has been shown after infection with H.
polygyrus [124]. Both N. brasiliensis and H. polygyrus
infections cause an upregulation of protease-activated recep-
tor (PAR)2 messenger RNA in the small intestine, and a
PAR2 agonist caused smooth muscle contractility, which
was enhanced in both parasite-infected groups and, for N.
brasiliensis at least, was dependent on STAT6 [124]. The
infection-induced hypercontractility in the presence of PAR2
agonist was lost when nerve conduction was blocked using
the neurotoxin TXX [124]. Whether smooth muscle hyper-
contractility plays a critical role in H. polygyrus expulsion
has yet to be determined.
Granuloma formation
A striking phenomenon in infection is the formation of gran-
ulomas around the site of larval invasion in the intestinal tract,
and they are more numerous in resistant strains of mice [125],
particularly following secondary H. polygyrus infection.
While granuloma formation is Th2 dependent, their function
has yet to be determined, either in damaging larval worms
encysted in the submucosal layer of the small intestine or in
tissue repair after H. polygyrus has departed into the lumen of
the gut [126]. Granulomas in both primary and secondary
infection consist of neutrophils, macrophages, dendritic cells,
and eosinophils; in secondary infection, CD4+ Th2 cells
and a high proportion of alternatively activated macrophages
rapidly migrate to the site of infection to surround the larvae
[80, 84, 85].
Immuno-regulatory cells in chronic infection
Regulatory T cells
Several categories of T cells exert suppressive or immuno-
modulatory effects, most prominently the subset of Tregs
expressing the transcription factor Foxp3. Sustained expres-
sion of Foxp3 is required to maintain Treg suppressive
function, as in its absence Tregs acquire effector T-cell
functions [127], and conversely, the forced expression of
Foxp3 confers suppressor function to CD4+CD25− T cells
[128]. Tregs are essential during infection to protect against
immune-mediated pathology while still allowing a suffi-
ciently robust response to clear the pathogen [129]. Indeed,
when Foxp3+ T cells are removed at early stages of an
infection with H. polygyrus, pathology of the small intestine
is significantly worse, with higher numbers of effector T
cells, IL-4, and IL-13 [130].
Foxp3 is constitutively expressed in a subset of regulatory
cells termed natural Tregs, but expression can also be induced
in resting Foxp3– peripheral T cells. Natural Tregs develop in
the thymus to limit autoreactive T cells, while inducible Tregs
leave the thymus as conventional T cells and are converted
through TGF-β, IL-10, and retinoic acid stimulation [129].
Treg induction is particularly favored in the intestine and gut-
associated lymphoid tissues, where H. polygyrus resides and
where TGF-β is highly enriched [32, 131]. Tregs, which
express the integrin CD103 (CD4+CD25+CD103+), are
more suppressive of CD4+ effector cells in vitro and
release significantly more IL-10 into culture supernatants after
stimulation with H. polygyrus primed dendritic cells than
CD4+CD25+CD103− Tregs [32].
A strong Treg response develops in the MLN and spleen of
H. polygyrus-infected mice, peaking at day 28 postinfection
[35]. CD25+CD103+ cells are the subset in the CD4+ compart-
ment that shows the greatest increase in cell number (compared
to CD25−CD103− effector cells and CD25+CD103− cells) [32,
35]. Most significantly, Foxp3 can also be induced in naive T
cells by HES in vitro, in a manner analogous to TGF-β, due to
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parasite-derived TGF-β-like activity [132] (discussed below).
Inhibition of TGF-β signaling during H. polygyrus infection
using the inhibitor SB431542 reduces adult worm burden and
results in an increased Th2 response [132], while administra-
tion of anti-TGF-β neutralizing antibody has also been
reported to result in lower worm numbers [93]. When TGF-β
signaling is lost only on CD4+ T cells, in TGF-βRII DN mice
[133], there was no reduction in adult H. polygyrus burden
compared to wild-type mice; in fact, H. polygyrus is more
fecund [134, 135]. This is likely due to excessive IFN-γ
production in the absence of CD4+ TGF-β signaling, as when
IFN-γ-deficient TGF-βRII DN mice were infected with H.
polygyrus, fewer adult worms survived after 28 days than in
IFN-γ-sufficient TGF-βRII DN mice [134], illustrating the
importance of both TGF-β and IFN-γ in determining suscep-
tibility to H. polygyrus.
H. polygyrus infection also induces CD8+ Tregs in the
lamina propria of the small intestine, which can inhibit T-cell
proliferation in vitro in an IL-10 and TGF-β independent
manner [36, 136].
Regulatory B cells
In addition to Tregs, regulatory B cells (Bregs) have also
been described that produce IL-10 and TGF-β, and can
dampen potentially harmful immune responses [137].
Bregs induced during helminth infections can not only
downregulate pathology elicited by schistosome eggs
[138] but also ameliorate immunopathologies such as
multiple sclerosis [139] and anaphylaxis [140] in humans
and mice. While the role of Bregs in parasite persistence
has not been directly investigated in H. polygyrus infec-
tion, suppressive B cells expand in the MLN of infected
C57BL/6 mice, which on transfer to uninfected hosts,
suppress airway allergy and inflammation in experimental
autoimmune encephalomyelitis [56].
Proregulatory DCs
Different subsets of DCs have been identified, which are
markedly altered during helminth infection. In the MLN of
H. polygyrus-infected mice, the proportion of CD11chighC-
D8αintermediate DCs declines in infection, indicating a reduced
migration of cells from the lamina propria [141]. Moreover,
there is a sharp increase in the proportion of tolerogenic
CD11clo DCs in the MLN; this cell type responds subopti-
mally to Toll-like receptor stimulation, is unable to prime a
strong Th2 response from T cells, but induces much higher
proportions of CD4+CD25− to express Foxp3 than the con-
ventional CD11chi subset [142, 143].
This effect was mirrored in an in vitro setting when OVA-
pulsed bone marrow-derived DCs (BMDCs) were cultured
with HES and showed lower costimulatory molecule
expression and cytokine output compared to untreated OVA-
pulsed BMDCs [144]. These cells also induced IL-10-
secreting CD4+CD25+Foxp3+ cell generation from CD4+
cocultures [144], indicating a potential regulatory pathway
initiated by H. polygyrus products.
Vaccine-induced immunity
Irradiated H. polygyrus larvae given orally stimulate protec-
tion against subsequent challenge [62, 145–148]. Notably, the
efficacy of this irradiated larval vaccine is diminished by the
coadministration of unirradiated larvae, indicating that the
development of adult worms is able to inhibit development
and/or expression of protective immunity against subsequent
reinfection [146, 147]. The ability of adult worms to suppress
protective immunity was further demonstrated by vaccine
failure in mice given irradiated larvae before or after receiving
adult parasites by intraintestinal laparatomy [146] or oral
gavage [149].
As well as infective (L3) stage larvae, live L4 larvae isolated
on days 4 or 6 postinfection from the intestinal wall of donor-
infected animals given subcutaneously, elicit an ~95–100 %
reduction in worms present 3 weeks after challenge compared
to unimmunized controls [150]. When immunization was per-
formed with late-stage L3 (isolated 2 days postinfection) or L5
larvae (isolated 8 days postinfection) a lower degree of protec-
tive immunity was induced (~60 and ~70 % reduction respec-
tively compared to unimmunized controls) [150].
Recently, an effective nonliving vaccine against H. poly-
gyrus has been developed, in the form of total HES admin-
istered with alum adjuvant, which induced sterile immunity
against infection [21]. Earlier work had shown that mice
immunized with a 60,000 mol wt HES-derived glycoprotein
isolated from HES prior to infection had lower egg burdens
than control mice, indicating an antifecundity effect of vac-
cination with this component [151].
Molecular basis of chronic infection
Parasite excretory–secretory products
The ability of helminth parasites to persist in the host for
many months or years, evading host immunity, is most
likely due to the secretion of active immunomodulatory
molecules [152]. The secretome of a parasite is likely to
continually mediate interactions with the host, through di-
rect contact with host cells in proximity to the worm, and
potentially systemically. Helminth-secreted immunomodu-
lators have been intensely studied, with some candidates
now being tested for treatments of other diseases and as
targets for antiparasite drugs [153].
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Early investigation of HES found immunomodulatory
factors that suppressed proliferation of mitogen-stimulated
lymphocytes [154] and Th2-dependent antibody produc-
tion to a bystander antigen through effects on T cells
[155]. More recently, HES has been shown to display a
wide range of immunomodulatory activities, including
inhibiting activation of DCs [144, 156], induction of
Tregs [132], and suppression of airway allergic inflam-
mation [157].
The individual components of the complex HES mix-
ture from adult worms have recently been defined
through proteomic and sequencing technology with the
identification of several hundred proteins in HES [5,
158]. Most prominent and numerous among the HES
products are >20 members of the Venom allergen/Ancy-
lostoma secreted protein-like (VAL) multigene family,
which show extensive sequence variation between genes
[5]. VALs have also been found to be highly immuno-
dominant as indicated by recognition of primary and
secondary infection serum, and monoclonal antibodies
[21], although their function is as yet undefined [5, 158].
These studies also found acetylcholinesterases and proteases
to be abundant in HES [5] along with apyrases, lipid-binding
proteins, lysosymes, globins, and vitellogenin homologues
[5, 158].
Stage and sex specificity of HES
A small number of studies have identified lifecycle-stage-
specific expression patterns of certain HES antigens. Infec-
tive larval stages of H. polygyrus secreted the highest levels
of proteolytic enzymes and acetylcholinesterase [159, 160],
which may be involved in migration through host tissues
directly after infection. Calreticulin has been shown to be
highly expressed in L4 larval stages and is localized in areas
associated with excretory–secretory processes [161]. A
TGF-β homologue has been shown to be abundantly
expressed in adults compared to larval stages, which may
indicate an immunomodulatory function when the adults
reside in the lumen of the intestine for long periods of time
[162]. A limited number of sex-specific adult antigens in
both HES and on the cuticle of the worms have also been
found [163].
H. polygyrus, autoimmunity and allergy
The immunomodulatory properties of H. polygyrus,
which extend far beyond the site of infection alone,
have led to many investigations of the potential for
and mechanisms of parasite downregulation of allergic
and autoimmune conditions, as discussed below, as well as
in the modulation of coinfections with other pathogens
(reviewed in [1]).
Allergy
H. polygyrus offers protection in several murine models of
allergy, including intestinal, airway, and cutaneous reac-
tions. Mice fed peanut extract administered alongside the
mucosal adjuvant cholera toxin produced peanut specific
IgE had elevated plasma histamine levels and exhibited
systemic anaphylactic shock symptoms. All phenotypes
were diminished in H. polygyrus-infected mice [164]. In
the presence of H. polygyrus, the peanut antigen-specific
IL-13 levels were drastically reduced, and these dampened
IL-13 levels along with protection from peanut allergy were
lost when mice were treated with neutralizing IL-10 anti-
body [164]. The source of IL-10 and the mechanism by
which it acts to dampen allergic responses to peanut antigen
during H. polygyrus infection have not yet been determined.
H. polygyrus-infected mice had reduced inflammatory
cell infiltrates and bronchoalveolar lavage eosinophilia in
experimentally induced airway allergy to both ovalbumin
[165–167] and the house dust mite antigen Der p 1 [166].
Protection against these allergens could be transferred by
MLN cells from infected mice, which contained a high
proportion of CD4+CD25+Foxp3+ T cells, or by transfer of
sorted CD4+CD25+ cells from infected mice, implicating the
action of Treg cells in protection [166]. H. polygyrus-
infected IL-10−/− mice were not protected from ovalbumin-
induced asthma [165]; however, MLN cells transferred from
IL-10−/− H. polygyrus infected mice could still protect from
allergy to these antigens, suggesting that IL-10 independent
mechanisms can confer protection from allergy [166].
Inflammatory bowel disease
Inflammatory bowel disease (IBD) is characterized by an
inappropriate inflammatory response of the gut to microbial
antigens. In humans, there are two main forms of the dis-
ease: Crohn’s disease (CD), which can affect the entire
length of the gut, and ulcerative colitis (UC), which is
localized only to the colon. There are many differing mouse
models of IBD (reviewed in [168]), and the effect of H.
polygyrus infection on controlling the disease has been
examined in a number of these models.
IL-10−/− mice suffer from spontaneous chronic colitis
[169] associated with excessive IFN-γ production [170].
Spontaneous colitis develops sporadically over several
months, but piroxicam treatment will induce rapid and uni-
form disease in IL-10-deficient mice [171, 172], which
likely occurs as a result of increased colonic epithelial cell
apoptosis causing a loss of barrier function to inflammatory
microbial stimuli [172]. When H. polygyrus was given to
piroxicam-treated IL-10−/− mice, the histological scores of
colitis severity were drastically reduced within 14 days
[173, 174]. LPMC from uninfected colitic mice released
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the inflammatory cytokines IFN-γ, IL-12p40, and IL-17A,
whereas LPMC from H. polygyrus-infected had significant-
ly reduced levels of these cytokines [173, 174].
Severe colitis also develops when RAG−/− mice are
reconstituted with IL-10−/− T cells and treated with pirox-
icam [175]. H. polygyrus colonization reduced gut inflam-
mation in this model, as shown by lower levels of IFN-γ and
IL-17 production by restimulated LPMC cells, and a drop in
colonic histological score from an average of above 3 (some
epithelial and muscle hypertrophy, mucus depletion, crypt
abscesses, and epithelial erosions) to less than 1 (some
mononuclear cell infiltrates in the lamina propria) [136,
176]. In RAG−/− mice that had been infected with H. poly-
gyrus, and subsequently drug-cleared of the infection prior
to transfer of the colitogenic IL-10−/− T cells and piroxicam
administration, mice still showed reduced levels of inflam-
mation compared to those that had never been infected
[176]. The authors reported that protection coincided with
downregulation of the costimulatory molecules CD80 and
CD86 on DCs, thus inhibiting antigen presentation to T cells
resulting in less inflammatory cytokine release [176].
TGF-βRΙΙ DN mice develop spontaneous colitis, which
is unable to be suppressed by H. polygyrus infection [135].
The inability of H. polygyrus to suppress colitis in this
model is likely due to the exacerbated IFN-γ levels seen
in TGF-βRΙΙ DN mice, which are not dampened during H.
polygyrus infection [135] and are known to aggravate intes-
tinal inflammation.
Intrarectal injection of trinitrobenzene sulfonic acid
(TNBS) administration also induces severe colitis in wild-
type mice. When mice that had been infected with H. poly-
gyrus for 10 days were given TNBS injection, they
exhibited markedly reduced TNBS-induced colonic damage
and inflammation and decreased Th1 cytokine mRNA ex-
pression compared to uninfected control mice, which was
accompanied by increased IL-10 secretion during H. poly-
gyrus infection [36, 177].
In contrast to other models of colitis, H. polygyrus seems
to intensify colitis caused by the murine bacterial pathogen
Citrobacter rodentium [178–180]. Disease exacerbation
could be due to the influx of alternatively activated macro-
phages during H. polygyrus infection, which are less able to
kill bacteria than classically activated macrophages [178], or
due to increased IL-10 production by DCs impairing mech-
anisms that kill C. rodentium, leading to more persistent
infection and colitis [180]. These studies exemplify the need
to understand the causes of colitis, and the mechanisms by
which helminths modulate disease progression, before hel-
minth therapy can be applied to human inflammatory bowel
diseases.
H. polygyrus is not the only parasitic nematode shown to
have modulatory effects on the onset of colitis; both T. spiralis
and excretory–secretory products from the hookworms
Ancylostoma caninum and Ancylostoma ceylanicum can also
ameliorate colitis progression in murine models, as reviewed
in [168]. In human clinical trials, ova from the pig intestinal
helminth parasite Trichuris suis reduced the severity of dis-
ease in some patients with UC and CD [181–183]. Although
initial clinical trials with T. suis are promising, the fact that the
therapy is not effective in 100% of patients illustrates the need
for further studies to understand the immunomodulatory
actions of these helminths in murine models of IBD.
Type 1 diabetes
Nonobese diabetic (NOD) mice spontaneously become dia-
betic (as measured by blood glucose levels of ≥ 200 mg/dl) by
25 weeks of age [184, 185]. When these mice are infected
with H. polygyrus at 5 weeks old, the onset of diabetes was
completely blocked, at least until 40 weeks of age [184, 185].
Administering H. polygyrus when NOD mice were 7 and
12 weeks of age resulted in less effective protection from
diabetes, yet onset was still delayed compared to untreated
NOD mice [185]. The severity of insulitis (the infiltration of
immune cells into the islets of Langerhans) was examined in
mice aged 13 weeks, and was sharply reduced in NOD mice
infected with H. polygyrus since the age of 5 weeks [185].
This reduction was maintained in H. polygyrus mice given
anti-CD25 antibody [185], suggesting thatH. polygyrusmod-
ulates type 1 diabetes (T1D) onset in a Treg-independent
manner, although whether this protection extends beyond the
13-week time point has not been examined.
There is the possibility that the modulatory effects of H.
polygyrus are due in part to changes in gut microbial com-
position during infection [186]. Studies to modify the mi-
crobial flora could address this, perhaps using fecal
transplants, which would allow transfer of the microflora
from H. polygyrus infected or naive mice to recipient mice
using methods described in [187].
Role of the microbiota
H. polygyrus is localized in the anterior small intestine
alongside a substantial microbial flora. The presence of spe-
cific species of bacteria within the gut is known to polarise
naive Tcells towards particular Th subset fates [188–190], and
as the outcome of H. polygyrus infection is dependent on the
immediate cytokine environment, it seems reasonable to
imagine that commensal microbes may alter the ability of
the murine immune system to cause worm expulsion.
Caremust therefore be takenwhen performing experiments
to compare the susceptibility toH. polygyrus in different mice,
as the mice may initially differ in their microbial flora. Vari-
ation in microbial flora may be due to the source of mice, as
mice of the same strain acquired from different vendors can
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harbor different gut microbes [188], perhaps due to diet or
housing conditions. The genotype of mice can also control
microbial populations, as has been shown to be the case for
MyD88-deficient mice, which have an altered microbial flora
compared to MyD88-sufficient mice as MyD88 controls the
release of some antimicrobial peptides [191].
After a 14-day infection with H. polygyrus in C57BL/6
mice, the abundance of Lactobacillaceae family members
was increased in the ileum compared to naive mice [186]. It
has yet to be demonstrated whether this shift is a helminth-
mediated mechanism that acts to promote the survival of H.
polygyrus within the murine host, or if it is simply as a
consequence of a changing immune environment, in which
bacteria of the Lactobacillaceae family are better able to
survive. To resolve this, further studies to investigate the
interplay among parasitic helminths, the microbial flora, and
the immune system are necessary.
Conclusions and implications for human infections
and disease
Parasitic helminth infections in humans and livestock
are still responsible for unacceptably high levels of
morbidity and economic loss worldwide. Understanding
the mechanisms necessary for expulsion of the model
gastrointestinal parasite H. polygyrus is likely to define
new pathways, which target the immune system to
provide the best protection against other helminth infec-
tions. The increasing prevalence of autoimmune diseases
in the Western world correlates with the increasing
absence of such helminth infections [192]. Our immune
systems have evolved to develop in the presence of
helminth parasite antigens, and it is vital to understand
whether the human immune system can function opti-
mally without this presence. Studies to isolate and un-
derstand how immunomodulatory factors secreted by
helminths such as H. polygyrus act to maintain gut
homeostasis are ongoing and will be invaluable both
in understanding the interactions between helminths
and the immune system and in the development of
new pharmaceutical therapies for autoimmune and aller-
gic diseases worldwide.
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